Accelerating trials site selection for a rare disease

Position your clinical trials for success from day one with trusted Clarivate intelligence.

This biopharmaceutical company – who was planning a late-stage clinical trial to support a rare disease indication extension for their drug – needed to identify sites and principal investigators with access to the trial’s representative patient sample.

The sponsor leveraged Cortellis granular sites data, overlaid with incidence and prevalence insights and U.S. claims data, to find suitable sites for its rare disease trial. To complement the site selection the sponsor worked with Clarivate Consulting Services to develop a custom investigator ranking analysis.

By equipping them with fast and reliable insights, the trial sponsor saved time, increased clinical operations efficiency and was confident they could meet enrolment targets.

Download this case study to find out how integrated clinical trials, epidemiology and real world data can help you optimize your clinical trials planning and operations.